Published in Nephron on January 01, 1993
Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol (2011) 2.18
Arterial thrombosis in the nephrotic syndrome. Postgrad Med J (1994) 1.08
Controversies in the treatment of idiopathic membranous nephropathy. Nat Rev Nephrol (2009) 1.02
Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome. Clin J Am Soc Nephrol (2013) 0.98
Transjugular renal biopsy in high-risk patients: an American case series. BMC Nephrol (2002) 0.97
Nephrotic syndrome in adults. BMJ (2008) 0.94
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag (2007) 0.86
Cerebral infarction as a complication of nephrotic syndrome: a case report with a review of the literature. J Korean Med Sci (2004) 0.78
Chapter 7: Idiopathic membranous nephropathy. Kidney Int Suppl (2011) (2012) 0.78
Brachiocephalic artery thrombosis in adult nephrotic syndrome. Indian J Nephrol (2011) 0.77
Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome. J Am Soc Nephrol (2015) 0.75
Cerebral infarction in patient with minimal change nephrotic syndrome. Indian J Nephrol (2013) 0.75
Myocardial infarction in a young man. Postgrad Med J (1998) 0.75
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet (2000) 8.08
A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med (2015) 4.95
Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int (1999) 3.09
Mechanism of grass-pollen-induced asthma. Lancet (1992) 2.92
Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of the frequency of donor lymphocytes which respond to each Ag-B-determined antigenic complex. J Exp Med (1975) 2.78
A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem (1995) 2.71
Quantitative physical chemistry analysis of acid-base disorders in critically ill patients. Anaesthesia (2001) 2.70
The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats. J Exp Med (1972) 2.66
Acute renal failure: time for consensus. Intensive Care Med (2001) 2.53
Specific unresponsiveness of recirculating lymphocytes ater exposure to histocompatibility antigen in F 1 hybrid rats. Nat New Biol (1971) 2.50
Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int (2006) 2.22
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20
Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med (2001) 2.17
Transanal haemorrhoidal artery echodoppler ligation and anopexy (THD) is effective for II and III degree haemorrhoids: a prospective multicentric study. Colorectal Dis (2010) 2.11
Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis. J Exp Med (1978) 2.02
Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology (2000) 2.02
The effects of plasmalyte-148 vs. Hartmann's solution during major liver resection: a multicentre, double-blind, randomized controlled trial. Minerva Anestesiol (2014) 2.01
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
The macrophagen in human rapidly progressive glomerulonephritis. Lancet (1976) 1.88
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med (1997) 1.86
Renal blood flow in experimental septic acute renal failure. Kidney Int (2006) 1.83
Myocardial cell injury in septic shock. Crit Care Med (1999) 1.82
Glomerulonephritis. Lancet (2005) 1.81
Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs (2007) 1.73
Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice. Minerva Anestesiol (2010) 1.73
PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.69
Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med (2010) 1.68
Release of lactate by the lung in acute lung injury. Chest (1997) 1.66
Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int (2001) 1.60
The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family. J Biol Chem (1997) 1.60
Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int (1987) 1.60
Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth (2014) 1.57
Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytes. J Exp Med (1975) 1.57
Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis (2001) 1.56
High-volume haemofiltration in human septic shock. Intensive Care Med (2001) 1.52
Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy. Epilepsia (1999) 1.50
Defective cytostatic activity of pulmonary alveolar macrophages in primary lung cancer. Chest (1990) 1.49
Antigenic heterogeneity of human mononuclear phagocytes: immunohistologic analysis using monoclonal antibodies. Blood (1983) 1.48
Current oxygenation practice in ventilated patients-an observational cohort study. Anaesth Intensive Care (2013) 1.45
The effect of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Crit Care Resusc (2002) 1.43
Postoperative hypothermia and patient outcomes after elective cardiac surgery. Anaesthesia (2011) 1.43
Oxygen consumption and lactate release by the lung after cardiopulmonary bypass and during septic shock. Crit Care Resusc (2000) 1.42
Trace element and vitamin concentrations and losses in critically ill patients treated with continuous venovenous hemofiltration. Crit Care Med (1999) 1.42
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol (1996) 1.40
Serum alpha 2-macroglobulin in haemodialysis patients: baseline and kinetic studies. Nephrol Dial Transplant (1993) 1.39
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes. Med J Aust (2001) 1.39
Plasma acid-base changes in chronic renal failure: a Stewart analysis. Int J Artif Organs (2005) 1.39
Australians with renal disease: a new national survey. Med J Aust (1999) 1.38
Comments on Efendijev et al.: temporal trends in cardiac arrest incidence and outcome in Finnish intensive care units from 2003 to 2013. Intensive Care Med (2015) 1.38
The role of macrophages in glomerulonephritis. Nephrol Dial Transplant (2001) 1.38
Effect of perfusion pressure on the splanchnic circulation after CPB: a pilot study. Minerva Anestesiol (2014) 1.37
Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int (1991) 1.35
Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol (1993) 1.35
Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis (2001) 1.34
Defining death in non-heart beating organ donors. J Med Ethics (2003) 1.32
The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy. Am J Pathol (1979) 1.31
The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant (2001) 1.30
The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy. Clin Exp Immunol (1979) 1.28
Local macrophage proliferation in human glomerulonephritis. Kidney Int (1998) 1.26
Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock (1998) 1.25
Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care (2002) 1.23
Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int (1993) 1.22
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci U S A (1998) 1.22
Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int (2000) 1.20
Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation (1983) 1.19
A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med (2000) 1.18
The aetiology and pathogenesis of cardiopulmonary bypass-associated metabolic acidosis using polygeline pump prime. Intensive Care Med (1999) 1.17
Membrane antigens of human cells of the monocyte/macrophage lineage studied with monoclonal antibodies. Pathology (1983) 1.17
Immunohistological studies with monoclonal antibodies. Methods Enzymol (1986) 1.16
Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system. Transplantation (1985) 1.16
Tissue culture of isolated human glomeruli. Pathology (1978) 1.15
A comparison of fixatives and immunohistochemical technics for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol (1982) 1.15
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. J Exp Med (1991) 1.15
Estimating unmeasured anions in critically ill patients: anion-gap, base-deficit, and strong-ion-gap. Anaesthesia (2002) 1.14
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol (1997) 1.14
Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells. J Clin Invest (1986) 1.13
The acid-base effect of changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration. Int J Artif Organs (2008) 1.11
A simple, reliable, and sensitive method for nonradioactive in situ hybridization: use of microwave heating to improve hybridization efficiency and preserve tissue morphology. J Histochem Cytochem (1996) 1.10
The proportion of lymphocytes capable of recognizing strong transplantation antigens in vivo. Adv Exp Med Biol (1973) 1.10
MIF expression in the rat brain: implications for neuronal function. Mol Med (1998) 1.10
Out of hospital outcome and quality of life in survivors of combined acute multiple organ and renal failure treated with continuous venovenous hemofiltration/hemodiafiltration. Intensive Care Med (1997) 1.10
Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant (1999) 1.10
The 3rd International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Int J Artif Organs (2005) 1.09
A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Physicians (1998) 1.08
Failure of continuous cardiac output measurement using the PiCCO Device during induced hypothermia: a case report. Crit Care Resusc (2004) 1.08
Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesth Intensive Care (2005) 1.08
Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration. Int J Artif Organs (2001) 1.07
Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol (1999) 1.07
Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kidney Dis (1992) 1.07
Cellular immune mechanisms in human glomerulonephritis: the role of mononuclear leucocytes. Springer Semin Immunopathol (1982) 1.07
Strong ions, weak acids and base excess: a simplified Fencl-Stewart approach to clinical acid-base disorders. Br J Anaesth (2004) 1.07
Hepatic anion flux during acute endotoxemia. J Appl Physiol (1985) (1995) 1.05
Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab Invest (1992) 1.05
Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol Dial Transplant (1997) 1.05
Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med (2000) 1.05
Long-term total parenteral nutrition. The concept of an artificial gut. JAMA (1970) 1.04
Nurses' attitudes to a medical emergency team service in a teaching hospital. Qual Saf Health Care (2006) 1.04